Restricted access to antiretroviral treatment for undocumented migrants: A bottle neck to control the HIV epidemic in the EU/EEA Global health

BMC Public Health

Volumn 15, Issue 1, 2015, Pages 1-13

  Deblonde, Jessika ^a   Sasse, André ^a   Del Amo, Julia ^b   Burns, Fiona ^c,d   Delpech, Valerie ^e   Cowan, Susan ^f   Levoy, Michele ^g   Keith, Lilana ^g   Pharris, Anastasia ^h   Amato Gauci, Andrew ^h   Noori, Teymur ^h  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f STATENS SERUM INSTITUT   (Denmark)

^g Platform for International Cooperation on Undocumented Migrants   (Belgium)

^h EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Access to health care; Antiretroviral treatment; Europe; HIV infection; Migrants

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

COMMUNICABLE DISEASE CONTROL; EPIDEMIC; ETHNIC GROUP; EUROPE; EUROPEAN UNION; FEMALE; HEALTH CARE DELIVERY; HIV INFECTIONS; HUMAN; HUMAN RIGHTS; INCIDENCE; MALE; MIGRANT; MIGRATION; PUBLIC HEALTH; RISK FACTOR; SOCIAL JUSTICE; TRANSMISSION;

ANTI-HIV AGENTS; COMMUNICABLE DISEASE CONTROL; EMIGRANTS AND IMMIGRANTS; EPIDEMICS; ETHNIC GROUPS; EUROPE; EUROPEAN UNION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMAN RIGHTS; HUMANS; INCIDENCE; MALE; PUBLIC HEALTH; RISK FACTORS; SOCIAL JUSTICE; TRANSIENTS AND MIGRANTS;

EID: 84949871289     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-2571-y     Document Type: Article

References (111)

1. EUROSTAT. European social statistics 2013 edition. Luxembourg: European Union; 2014.
2. UNAOC & PanosEurope. Media friendly glossary on migration. Marseille: Panos Europe Institute; 2014. Available at: http://www.ilo.org/wcmsp5/groups/public/ - -ed-protect/ - -protrav/ - -migrant/documents/publication/wcms-310235.pdf.
3. Triandafyllidou T. Undocumented migration: counting the uncountable. Data and trends across Europe. Brussels: European Commission, DG Research; 2009. Available at: http://ecdc.europa.eu/en/publications/Publications/hiv-aids-surveillance-report-Europe-2013.pdf.
4. ECDC/WHO Europe. HIV/AIDS surveillance in Europe 2013. Stockholm: European Centre for Disease Prevention and Control; 2014. Available at: http://ecdc.europa.eu/en/publications/-layouts/forms/Publication-DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1217.
5. Hernando V, Pharris A, Alvarez-del Arco D, Rivero Y, Monge S, Noori T, et al. HIV among migrants in the EU/EEA: epidemiological trends 2007-2012. Granada (Spain): Oral Presentation; 2014.
6. Hernando V, Alvarez-del Arco D, Alejos B, Monge S, Amato-Gauci AJ, Noori T, et al. HIV infection in migrant populations in the european union and european economic area in 2007-2012: an epidemic on the move. J Acquir Immune Defic Syndr. 2015;70(2):204-11.
7. ECDC. Migrant health: sexual transmission of HIV within migrant groups in the EU/EEA and implications for effective interventions. Stockholm: European Centre for Disease Prevention and Control; 2013. Available at: http://www.ecdc.europa.eu/en/publications/Publications/Migrant-health-sexual-transmission.pdf.
8. Fakoya I, Alvarez-del Arco D, Woode-Owusu M, Monge S, Rivero-Montesdeoca Y, Delpech V, et al. A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy. BMC Public Health. 2015;15:561.
9. Rice BD, Elford J, Yin Z, Delpech VC. A new method to assign country of HIV infection among heterosexuals born abroad and diagnosed with HIV. AIDS. 2012;26(15):1961-6.
10. Alvarez-del Arco D. HIV acquisition among migrants living in Europe: results from aMASE. PS3/5. Barcelona: European AIDS Clinical Society; 2015.
11. ECDC/WHO Europe. HIV/AIDS surveillance in Europe 2012. Stockholm: European Centre for Disease Prevention and Control; 2013. Available at: http://www.ecdc.europa.eu/en/publications/Publications/hiv-aids-surveillance-report-2012-20131127.pdf.
12. ECDC. Background and methods. Monitoring the implementation of the Dublin Declaration to fight HIV/AIDS in Europe and Central Asia. Stockholm: European Centre for Disease Prevention and Control; 2013. Available at: http://ecdc.europa.eu/en/publications/Publications/dublin-declaration-background-methods.pdf.
13. Commission of the European Communities. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. Combating HIV/AIDS in the European Union and neigbouring countries, 2009-2013. COM(2009)569. Brussels; 2009
14. European Commission. European Commission Staff Working Document. Action Plan on HIV/AIDS in the EU and neighbouring countries: 2014-2016. SWD(2014)106 final. Brussels; 2014.
15. Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13(5):459-64.
16. Garnett P. The basic reproductive rate of infection and the course of HIV epidemics. AIDS Patient Care STDS. 1998;12:435-49.
17. Poundstone KE, Strathdee SA, Celentano DD. The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiol Rev. 2004;26(1):22-35.
18. Fenton K, Chinouya M, Davidson O, Copas A. HIV testing and high risk sexual behaviour among Londons migrant African communities: a participatory research study. Sex Transm Infect. 2002;78(4):241-5.
19. Fenton KA, Mercer CH, McManus S, Erens B, Wellings K, Macdowall W, et al. Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey. Lancet. 2002;365(9466):1246-55.
20. Gras MJ, Weide JF, Langendam MW, Coutinho RA, van den Hoek A. HIV prevalence, sexual risk behaviour and sexual mixing patterns among migrants in Amsterdam, the Netherlands. AIDS. 1999;13(14):1953-62.
21. Marsicano E, Lydie N, Bajos N. Migrants from over there or racial minority here? Sexual networks and prevention practices among sub-Saharan African migrants in France. Cult Health Sex. 2013;15(7):819-35.
22. Doerner R, McKeown E, Nelson S, Anderson J, Low N, Elford J. Sexual mixing and HIV risk among ethnic minority MSM in Britain. AIDS Behav. 2012;16(7):2033-41.
23. Evans AR, Hart GJ, Mole R, Mercer CH, Parutis V, Gerry CJ, et al. Central and East European migrant men who have sex with men: an exploration of sexual risk in the UK. Sex Transm Infect. 2011;87(4):325-30.
24. Fenton KA, Chinouya M, Davidson O, Copas A, on behalf of the MAYISHA research team. HIV transmission risk among sub-Saharan Africans in London travelling to their countries of origin. AIDS. 2001;15(11):1442-5.
25. Kramer MA, van Veen MG, de Coul EL, Geskus RB, Coutinho RA, van de Laar MJ. Migrants travelling to their country of origin: a bridge population for HIV transmission? Sex Transm Infect. 2008;84(7):554-5.
26. Richens J. Sexually transmitted infections and HIV among travellers: a review. Travel Med Infect Dis. 2006;4(3-4):184-95.
27. PICUM. Strategies to end double violence against undocumented women. Protecting rights and ensuring justice. Brussels: Platform for International Cooperation on Undocumented Migrants; 2012. Available at: http://picum.org/picum.org/uploads/publication/Double%20Violence%20Against%20Undocumented%20Women%20-%20Protecting%20Rights%20and%20Ensuring%20Justice.pdf.
28. Woodward A, Howard N, Wolffers I. Health and access to care for undocumented migrants living in the European Union: a scoping review. Health Policy Plan. 2014;29(7):818-30.
29. Mayock P, Sheridan S. Migrant women and homelessness: key findings from a biographical study of homeless women in Ireland. Dublin: School of Social Work and Social Policy and Children's research Centre, Trinity College Dublin; 2012. Availabe at: https://www.academia.edu/2564997/Migrant-Women-and-Homelessness-Key-Findings-from-a-Biographical-Study-of-Homeless-Women-in-Ireland.
30. Sebo P, Jackson Y, Haller D, Gaspoz JM, Wolff H. Sexual and reproductive health behaviors of undocumented migrants in Geneva: a cross sectional study. J Immigr Minor Health. 2011;12:61-4.
31. Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61-4.
32. Waters L, Sabin CA. Late HIV presentation: epidemiology, clinical implications and management. Expert Rev Anti-Infect Ther. 2011;9(10):877-89.
33. Burns FM, Imrie JY, Nazroo J, Johnson AM, Fenton KA. Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care. 2007;19(1):102-8.
34. Monge S. For COHERE in EuroCoord. Mortality in migrants living with HIV in Western Europea countries: differences by geographical origin and gender. Brussels (Belgium); 2013.
35. Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, et al. Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain. HIV Med. 2013;14(5):273-83.
36. Alvarez-del Arco D, Monge S, Azcoaga A, Rio I, Hernando V, Gonzalez C, et al. HIV testing and counselling for migrant populations living in high-income countries: a systematic review. Eur J Pub Health. 2013;23(6):1039-45.
37. ECDC. HIV testing: Increasing uptake and effectiveness in the European Union. Stockholm: European Centre for Disease Prevention and Control; 2010. Available at: http://ecdc.europa.eu/en/publications/publications/101129-ter-hiv-testing-evidence.pdf.
38. PICUM. Access to health care for undocumented migrants in Europe. Brussels: Platform for International Cooperation on Undocumented Migrants; 2007. Available at: http://picum.org/picum.org/uploads/file-/Access-to-Health-Care-for-Undocumented-Migrants.pdf.
39. Spencer S, Hughes V. Outside and In: Legal entitlements to health care and education for migrants with irregular status in Europe. Oxford: COMPAS University of Oxford; 2015.
40. Gennotte AF, Semaille P, Ellis C, Necsoi C, Abdulatif M, Chellum N, et al. Feasibility and acceptability of HIV screening through the use of rapid tests by general practitioners in a Brussels area with a substantial African community. HIV Med. 2013;14:57-60.
41. Loos J, Manirankunda L, Hendrickx K, Remmen R, Nöstlinger C. HIV testing in primary care: feasibility and acceptability of provider initiated HIV testing and counseling for Sub-Saharan African migrants. AIDS Educ Prev. 2014;26(1):81-93.
42. Manirankunda L, Loos J, Alou TA, Colebunders R, Nöstlinger C. It's better Not to know: perceived barriers to HIV voluntary counseling and testing among Sub-Saharan African migrants in Belgium. AIDS Educ Prev. 2009;21(6):582-93.
43. NAT. HIV and Black African Communities in the UK. London: National AIDS Trust; 2014. http://fra.europa.eu/sites/default/files/fra-uploads/1827-FRA-2011-Migrants-in-an-irregular-situation-EN.pdf.
44. Boyd AE, Murad S, O'Shea S, De Ruiter A, Watson C, Easterbrook PJ. Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Med. 2005;6(2):59-65.
45. Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, Fakoya A, et al. Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS. 2008;22(1):115-22.
46. Prost A, Elford J, Imrie J, Petticrew M, Hart G. Social, behavioural, and intervention research among people of Sub-Saharan African origin living with HIV in the UK and Europe: literature review and recommendations for intervention. AIDS Behav. 2008;12(2):170-94.
47. Thomas F, Aggleton P, Anderson J. If I cannot access services, then there is no reason for me to test: the impacts of health service charges on HIV testing and treatment amongst migrants in England. AIDS Care. 2010;22(4):526-31.
48. Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(3 Suppl 2):18734.
49. Anderson M, Elan G, Gerver S, Solarin I, Fenton K, Easterbrook P. HIV/AIDS-related stigma and discrimination: Accounts of HIV-positive Caribbean people in the United Kingdom. Soc Sci Med. 2008;67:790-8.
50. Dodds C, Keogh P, Chime O, Haruperi T, Nabulya B, SsanyySseruma W. Outsider status: stigma and discrimination experienced by gay men and African people with HIV. London: Sigma research; 2004.
51. Dima AL, Stutterheim SE, Lyimo R, de Bruin M. Advancing methodology in the study of HIV status disclosure: The importance of considering disclosure target and intent. Soc Sci Med. 2014;108:166-74.
52. Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one's HIV-positive status, stigma and social support. AIDS Care. 2008;20(10):1266-75.
53. Flowers P, Davis M, Hart G, Rosengarten M, Frankis J, Imrie J. Diagnosis and stigma and identity amongst HIV positive Brack Africans living in the UK. Psychol Health. 2006;21:109-22.
54. Elford J, Ibrahim F, Bukutu C, Anderson J. Disclosure of HIV status: the role of ethnicity among people living with HIV in London. J Acquir Immune Defic Syndr. 2008;47(4):514-21.
55. Stutterheim SE, Shiripinda I, Bos AER, Pryor JB, de Bruin M, Nellen JFJB, et al. HIV status disclosure among HIV-positive African and Afro-Caribbean people in the Netherlands. AIDS Care. 2011;23(2):195-205.
56. FRA. Fundamental rights of migrants in an irregular situation in the European Union. Luxembourg: European Agency for Fundamental Rights; 2011. Available at: http://fra.europa.eu/en/publication/2012/fundamental-rights-migrants-irregular-situation-european-union.
57. Bodenmann P, Vaucher P, Wolff H, Favrat B, de Tribolet F, Masserey E, et al. Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study. BMC Infect Dis. 2009;9:34.
58. Jackson Y, Sebo P, Aeby G, Bovier P, Ninet B, Schrenzel J, et al. Prevalence and associated factors for chlamydia trachomatis infection among undocumented immigrants in a primary care facility in Geneva, Switzerland: a cross-sectional study. J Immigr Minor Health. 2010;12(6):909-14.
59. Sullivan MM, Rehm R. Mental health of undocumented Mexican immigrants: a review of the literature. Adv Nurs Sci. 2005;28(3):240-51.
60. Wahlberg A, Kallestal C, Lundgren A, Essen B. Causes of death among undocumented migrants in Sweden,1997-2010. Available at: http://www.globalhealthaction.net/index.php/gha/article/view/24464. Global Health Action. 2014;7.
61. Wolff H, Stalder H, Epiney M, Walder A, Irion O, Morabia A. Health care and illegality: a survey of undocumented pregnant immigrants in Geneva. Soc Sci Med. 2005;60(9):2149-54.
62. Chauvin P, Simmonot N, Vanbiervliet F. Access to healthcare for vulnerable groups in the European Union in 2012. Paris: Médecins du Monde; 2013. Available at: http://www.europarl.europa.eu/document/activities/cont/201302/20130208ATT60776/20130208ATT60776EN.pdf.
63. Biswas D, Kristiansen M, Krasnik A, Norredam M. Access to healthcare and alternative health-seeking strategies among undocumented migrants in Denmark. BMC Public Health. 2011;11:560.
64. Larchanche S. Intangible obstacles: health implications of stigmatization, structural violence, and fear among undocumented immigrants in France. Soc Sci Med. 2012;74(6):858-63.
65. Mladovsky P, Rechel B, Ingleby D, McKee M. Responding to diversity: an exploratory study of migrant health policies in Europe. Health Policy. 2012;105(1):1-9.
66. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2006;381(9873):1235-45.
67. Chauvin P, Simmonot N, Vanbiervliet F. Access to healthcare in Europe in times of crisis and rising xenophobia. Paris: Médecins du Monde; 2013. Available at: http://www.doktersvandewereld.be/sites/www.doktersvandewereld.be/files/publicatie/attachments/pdf-report-crisis-and-rising-xenophobia.pdf.
68. EU. Dublin Declaration on Partnership to fight HIV/AIDS in Europe and Central Asia. Dublin: Irish EU Presidency; 2004.
69. UNGASS. UN Declaration of committement on HIV/AIDS. United Nations General Assembly Resolution R.A/RES/S-26/2. 2001.
70. WHO Europe. Scaling up HIV testing and counselling in the WHO European Region. A policy framework. Copenhagen: World Health Organisation Regional Office Europe; 2010. Available at: http://www.euro.who.int/-data/assets/pdf-file/0007/85489/E93715.pdf.
71. ECDC. Guidance HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: European Centre for Disease Prevention and Control; 2010. Available at: http://ecdc.europa.eu/en/publications/publications/101129-gui-hiv-testing.pdf.
72. Deblonde J, Meulemans H, Callens S, Luchters S, Temmerman M, Hamers FF. HIV testing in Europe: Mapping policies. Health Policy. 2011;103(2-3):101-10.
73. Alvarez-del Arco D, Monge S, Caro-Murillo AM, Ramirez-Rubio O, Azcoaga-Lorenzo A, Belza MJ, et al. HIV testing policies for migrants and ethnic minorities in EU/EFTA Member States. Eur J Pub Health. 2014;24(1):139-44.
74. Mounier-Jack S, Nielsen S, Coker RJ. HIV testing strategies across European countries. HIV Med. 2008;9:13-9.
75. WHO. Service delivery approaches to HIV testing and counselling (HTC): a strategic HTC programme framework. Geneva: World Health Organisation; 2012. Available at: http://apps.who.int/iris/bitstream/10665/75206/1/9789241593877-eng.pdf?ua=1.
76. ECDC. From Dublin to Rome: ten years of responding to HIV in Europe and Central Asia. Stockholm: European Centre for Disease Prevention and Control; 2014. Available at: http://www.ecdc.europa.eu/en/publications/Publications/dublin-rome-10-years-hiv-europe-central-asia.pdf.
77. Martinez O, Wu E, Sandfort T, Dodge B, Carballo-Dieguez A, Pinto R, et al. Evaluating the impact of immigration policies on health status among undocumented immigrants: a systematic review. J Immigr Minor Health. 2015;17(3):947-70.
78. Kentikelenis A, Karanikolos M, Reeves A, McKee M, Stuckler D. Greece's health crisis: from austerity to denialism. Lancet. 1922;383(9918):748-53.
79. Vazquez ML, Terraza-Nunez R, Vargas I, Rodriguez D, Lizana T. Health policies for migrant populations in three European countries: England, Italy and Spain. Health Policy. 2011;101(1):70-8.
80. Cuadra CB. Right of access to health care for undocumented migrants in EU: a comparative study of national policies. Eur J Pub Health. 2012;22(2):267-71.
81. Council of the European Union. Council conclusions on equity and health in all policies. Available at: http://www.consilium.europa.eu/uedocs/cms-data/docs/pressdata/en/lsa/114994.pdf. Brussels; 2010.
82. FRA. Apprehension of migrants in an irregular sistuation-fundamental rights considerations. Luxembourg: European Agency for Fundamental Rights; 2013. Available at: http://fra.europa.eu/sites/default/files/fra-2013-apprehension-migrants-irregular-situation-en.pdf.
83. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ Count-Guided Interruption of Antiretroviral Treatment. N Engl J Med. 2006;355:2283-96.
84. Mocroft A, Lundgren JD, Sabin ML, Monforte AD, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9), e1001510.
85. The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit SP, Sabin C, Mocroft A, et al. All-cause mortality in treated HIV-infected adults with CD4 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. 2012;41(2):433-45.
86. The Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study. AIDS. 2010;24(10):1537-48.
87. When To Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352-63.
88. The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795-807.
89. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342(13):921-9.
90. Pilcher CD, Tien HC, Eron JJ, Vernazza PL, Leu SY, Stewart PW, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004;189(10):1785-92.
91. Maggiolo F, Leone S. Is HAART modifying the HIV epidemic? Lancet. 2014;376(9740):492-3.
92. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397-404.
93. Wood E, Kerr T, Marshall BDL, Li K, Zhang R, Hogg RS, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.
94. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2014;376(9740):532-9.
95. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5(6), e11068.
96. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092-8.
97. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
98. Del Romero J, Castilla J, Hernando V, Rodriguez C, Garcia S. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ. 2010;340:c2205.
99. Rodger A. HIV transmission risk through condemless sex if HIV+ partner on suppressive ART: the PARTNER study. 21st Conference on Retroviruses and opportunistic Infections, Boston, Abstract 153LB. 2014.
100. Rodger A, Bruun T, Weait M, Vernazza P, Collins S, Estrada V, et al. Partners of people on ART-a New Evaluation of the Risks (The PARTNER study): design and methods. BMC Public Health. 2012;12:296.
101. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Available at: http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565-eng.pdf?ua=1. World Health Organization; 2015.
102. Dodds C. ARVs for prevention: a research agenda for the social sciences. Oral presentation at TasP PrEP Evidence Summit 2013, London. London: TasP PrEP Evidence Summit; 2013. Full presentation available at: http://sigmaresearch.org.uk/presentations/hiv/talk2013g/.
103. Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 US areas. J Acquir Immune Defic Syndr. 2012;60(1):77-82.
104. Helleberg M, Haggblom A, Sonnerborg A, Obel N. HIV care in the Swedish-Danish HIV Cohort 1995-2010. Closing the Gaps. PLoS One. 2013;8(8), e72257.
105. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010;24(17):2665-78.
106. Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164-71.
107. Thierfelder C, Weber R, Elzi L, Furrer H, Cavassini M, Calmy A, et al. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Med. 2012;13(2):118-26.
108. Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793-800.
109. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organisation; 2013. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727-eng.pdf?ua=1.
110. Hall HI, Tang T, Westfall AO, Mugavero MJ. HIV care visits and time to viral suppression, 19 U.S. Jurisdictions, and implications for treatment, prevention and the national HIV/AIDS strategy. PLoS One. 2013;8(12), e84318.
111. Nosyk B, Montaner JSG, Colley G, Lima VD, Chan K, Heath K, et al. The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis. 2014;14(1):40-9.